Pneumococcal Infections
Showing 76 - 100 of 8,231
Pneumococcal Infections, Meningococcal Infections Trial in Welwyn Garden City, Gloucester (menjugate, Men C conjugate vaccine,
Completed
- Pneumococcal Infections
- Meningococcal Infections
- menjugate
- +3 more
-
Welwyn Garden City, Hertfordshire, United Kingdom
- +1 more
Sep 29, 2020
Meningococcal Infections Trial in Worldwide (MenACYW conjugate vaccine, Meningococcal group A, C, W-135, and Y conjugate
Active, not recruiting
- Meningococcal Infections
- MenACYW conjugate vaccine
- +5 more
-
Chlumec Nad Cidlinou, Czechia
- +30 more
Jan 4, 2023
Pneumococcal Infection Trial in Puerto Rico, United States (V110, V114, mRNA-1273)
Recruiting
- Pneumococcal Infection
- V110
- +4 more
-
North Hollywood, California
- +45 more
Aug 11, 2022
Understanding Pneumococcal Carriage and Disease 2017-2020
Active, not recruiting
- Streptococcus Pneumoniae Infection
- +2 more
- Nasopharyngeal swab
- blood sampling
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine
Oct 19, 2020
Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia Trial in Minsk (Vaccination with pneumococcal conjugate vaccine
Enrolling by invitation
- Multiple Myeloma
- +3 more
- Vaccination with pneumococcal conjugate vaccine (PCV13)
- Standard Antibacterial Prophylaxis
-
Minsk, BelarusMinsk Scientific Practical Center of Surgery, Transplantation an
Sep 1, 2020
Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Anaheim, California
- +28 more
Mar 23, 2022
HIV Trial (Influenza Virus Vaccine, Pneumococcal Vaccine, Polyvalent (23-valent), Lamivudine)
Withdrawn
- HIV Infections
- Influenza Virus Vaccine
- +2 more
- (no location specified)
Oct 28, 2021
Infectious Diseases Trial in Oxford (DTaP/IPV/Hib vaccine, 13 valent Pneumococcal Conjugate Vaccine, Rotavirus vaccine)
Completed
- Infectious Diseases
- DTaP/IPV/Hib vaccine
- +5 more
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine
Sep 17, 2021
Infections, Streptococcal Trial in Germany (Pneumococcal vaccine GSK2830930A, Synflorix™)
Completed
- Infections, Streptococcal
- Pneumococcal vaccine GSK2830930A
- Synflorix™
-
Kehl, Baden-Wuerttemberg, Germany
- +3 more
Feb 8, 2021
Infections, Streptococcal, Streptococcus Pneumoniae Trial in Helsinki (Pneumococcal conjugate vaccine GSK1024850A, GSK
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae
- Pneumococcal conjugate vaccine GSK1024850A
- +2 more
-
Helsinki, FinlandGSK Investigational Site
Nov 20, 2020
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™, PNEUMOVAX™23)
Completed
- Pneumococcal Infections
- V114
- +2 more
-
Palo Alto, California
- +51 more
Sep 23, 2022
Pneumococcal Infections Trial in United States (Multivalent, 13vPnC)
Completed
- Pneumococcal Infections
- Multivalent
- 13vPnC
-
Fayetteville, Arkansas
- +38 more
Feb 27, 2021
Meningococcal Disease, Pneumococcal Disease, Haemophilus Influenzae Serotype b Disease Trial in London (Menjugate, Menitorix,
Completed
- Meningococcal Disease
- +4 more
- Menjugate
- +2 more
-
London, United KingdomSt George's Vaccien Institute
Sep 29, 2020
Pneumococcal Disease Trial in United States (20vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
-
Fayetteville, Arkansas
- +41 more
May 24, 2022
Complement Deficiency, Antibody Deficiency, Chronic Sinus Infection Trial in France (Immunological diagnosis tests)
Terminated
- Complement Deficiency
- +9 more
- Immunological diagnosis tests
-
Armentières, France
- +18 more
Sep 16, 2020
Pneumococcal Disease Trial in Worldwide (V116, PCV20)
Recruiting
- Pneumococcal Disease
- V116
- PCV20
-
Birmingham, Alabama
- +67 more
Aug 17, 2022
Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Poland (GSK1024805A, Prevenar, Infanrix hexa)
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae Vaccines
- GSK1024805A
- +4 more
-
Bydgoszcz, Poland
- +5 more
Jan 11, 2021
Infections, Streptococcal Trial in Czechia (Pneumococcal vaccine GSK2189242A (formulation 1), Pneumococcal vaccine GSK2189242A
Completed
- Infections, Streptococcal
- Pneumococcal vaccine GSK2189242A (formulation 1)
- +4 more
-
Chomutov, Czechia
- +9 more
Oct 15, 2020
HIV Trial in Puerto Rico, United States (Pneumococcal 7-valent conjugate vaccine, Pneumococcal polysaccharide vaccine, Hepatitis
Completed
- HIV Infections
- Pneumococcal 7-valent conjugate vaccine
- +3 more
-
Birmingham, Alabama
- +25 more
Oct 28, 2021
Pneumococcal Infections Trial in Worldwide (Rotarix™, Infanrix™ hexa, V114)
Completed
- Pneumococcal Infections
- Rotarix™
- +3 more
-
South Brisbane, Queensland, Australia
- +59 more
Dec 1, 2021
Pneumococcal Infections Trial in Seoul (NBP606, Prevnar13)
Completed
- Pneumococcal Infections
- NBP606
- Prevnar13
-
Seoul, Korea, Republic ofConfidential
Apr 17, 2020
Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Cuernavaca, Monterrey, Mexico (Synflorix (3-Dose),
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae Vaccines
- Synflorix (3-Dose)
- +4 more
-
Cuernavaca, Morelos, Mexico
- +2 more
Feb 8, 2021
Pneumococcal Disease Trial in United States (Experimental 20-valent pneumococcal conjugate vaccine (20vPnC), Saline, Influenza
Completed
- Pneumococcal Disease
- Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Mobile, Alabama
- +62 more
Jun 15, 2022